Screener
Ionis Pharmaceuticals IONS Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Ionis Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed April 30, 2025. Open the filing →
- Filed
- Apr 30, 2025
- Fiscal quarter
- Q1 FY2025
- Calendar quarter
- Q1 2025
- Accession
- 0000874015-25-000123
FAQ
- What is Ionis Pharmaceuticals's free cash flow margin?
- Ionis Pharmaceuticals (IONS) reported free cash flow margin of -77.4% in Q1 2025.
- How has Ionis Pharmaceuticals's free cash flow margin changed year-over-year?
- Ionis Pharmaceuticals's free cash flow margin decreased by 31.3% year-over-year, from -58.9% to -77.4%.
- What is the long-term trend for Ionis Pharmaceuticals's free cash flow margin?
- Over 4 years (2020 to 2024), Ionis Pharmaceuticals's free cash flow margin has grown at a 420.1% compound annual growth rate (CAGR), from 0.1% to -77.5%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Ionis Pharmaceuticals's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude